- PR Newswire•23 hours ago
IRVINE, Calif., Sept. 29, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received CE Mark for its INSPIRIS RESILIA aortic valve, the first in a new class of resilient heart valves. Incorporating the advanced RESILIA tissue, the INSPIRIS valve leverages features of the trusted PERIMOUNT Magna Ease valve and includes the proprietary VFit technology, which is designed for potential future valve-in-valve procedures. "Heart valve patients are living longer and want to maintain their active lifestyles.
- Investor's Business Daily•8 days ago
Edwards Lifesciences and Glaukos are among medical products companies with top-performing stocks of late.
Edwards Lifesciences Corp. (EW)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||117.00 x 100|
|Ask||120.22 x 500|
|Day's Range||118.33 - 121.72|
|52wk Range||70.62 - 121.73|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||49.28|
|Avg Vol (3m)||1,260,128|
|Dividend & Yield||N/A (N/A)|